Aust J Gen Pract
November 2024
Background: Recommencement of oral anticoagulation (OAC) for patients post-intracerebral haemorrhage (ICH) remains a challenging decision for clinicians. High-quality evidence to assist with this decision is lacking and current guidelines primarily focus on balancing thromboembolic and bleeding risk.
Objective: This study evaluated the literature and current guidelines for recommencement of OAC in patients who have experienced an incident ICH.